Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
6,687
Total Claims
$830K
Drug Cost
424
Beneficiaries
$1,957
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-86%
Opioid rate vs peers
0.5% vs 3.8% avg
+67%
Cost per patient vs peers
$1,957 vs $1,174 avg
+42%
Brand preference vs peers
12.6% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.5%
Opioid Rate
36
Opioid Claims
$437
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 832 claims · $695K
Generic: 5,784 claims · $130K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 70 | $106K |
| Semaglutide | 55 | $105K |
| Apixaban | 53 | $89K |
| Dulaglutide | 41 | $78K |
| Tirzepatide | 44 | $49K |
| Dapagliflozin Propanediol | 24 | $30K |
| Insulin Glargine,hum.Rec.Anlog | 40 | $23K |
| Insulin Degludec | 30 | $22K |
| Insulin Degludec | 17 | $16K |
| Insulin Aspart | 11 | $9,907 |
| Levothyroxine Sodium | 63 | $5,758 |
| Duloxetine Hcl | 128 | $4,730 |
| Estradiol | 62 | $3,915 |
| Levothyroxine Sodium | 303 | $3,566 |
| Rosuvastatin Calcium | 178 | $3,563 |
Prescribing Profile
Patient Profile
72
Avg Age
64%
Female
1.02
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About